03/09/2020
37.7 percent of the samples of analyzed antibiotics failed to meet the pharmacopoeial specifications in Nairobi, Kenya (exposed)
The report published by BioMed Research International on June 13 with the approval of Kenya Medical Research Institute (KEMRI) and Kenyatta University revealed that how Kenyan lives are being put at risk due to the counterfeited amoxicillin tablets.
The research stated that about 37.7 per cent of the samples analyzed failed to meet the pharmacopoeial specifications and were all imported products," the research states adding that some were of different quality and were poorly produced. It also ascertained that over 30 per cent of the antibiotics stored in Nairobi pharmacies were imported from India and China as retailers opted against selling the locally manufactured antibiotic.
The authors warned that the counterfeit drugs may cause the body to resist Amoxicillin which may hamper treatment of bacterial infections. Therefore, there is a need to extend the study to other counties to inform on the situation of antibiotic quality in the Kenyan market. Strict regulation is also essential to guarantee compliance with good manufacturing practices by pharmaceutical manufacturers," the survey states.